Take the Uncertainty Out of Your Dose Decisions
Clinically validated pre-term, neonate, paediatric and adolescent drug models
DoseMe leverages clinically validated pharmacokinetic drug models, specifically designed for infants, children and adolescents, as well as patient characteristics, drug concentrations and genotype to guide dose optimisation.
Our paediatric models cover a range of therapies including antibiotics, anti-coagulants, immunosuppressants, anticonvulsants and more.
Benefits your patients and health system
Proven to save time, reduce adverse drug events and improve patient outcomes, DoseMe can be rapidly deployed with minimal resources to optimise your therapeutic drug monitoring and standardise care throughout your entire health service.
Reduce Clinical Variation
Standardise care with a data-guided approach to personalised dosing across entire health service for rigor and reproducibility.
Save Time, Reduce Assay Costs
Support for random times assays, to reduce unnecessary serum sampling and improve your patients experience.
Minimise Drug-related Toxicities
Algorithms account for variability in genotype, metabolic enzymes and interacting drugs.
Your Data, Your Custom Model
Want to develop a model for a specialised paediatric population using your own data? We make this simple and safe through our custom model process.
Your Workflow, Only Simpler
Standardise dose adjustments throughout your health system
Quickly and easily calculate an individualised dose to a range of therapeutic targets, including AUC, Peak-Trough and Time in Range and compare this to your hospital guidelines and label recommendations to optimise decision making and standardise care at your hospital.
Real-time visualisation of PK-PD
Easy, Quick and Simple
Drug monitoring no longer needs to be laborious or trial and error. In just a few clicks, you can accurately calculate an individualised dose modelled on your patients PK-PD from just one assay to reach your therapeutic target quicker.